Alzheimer's Society
Jump to: content Jump to: navigation   Accessibility Contact Us Mobile Shop

Go to Graphical version

 

Transdermal vaccine effective in treating Alzheimer's disease in mouse model

Published 13 November 2007

There has been tremendous interest about developing a vaccine to treat Alzheimer’s disease.

'Although side effects have been a problem in initial human vaccine studies, this new study is potentially very exciting. The prospect of a practical and non-invasive vaccine delivered through this new method is particularly welcome. However, more research and evaluation is now needed to investigate whether it is a safe and effective method to deliver the vaccine in humans.'

Clive Ballard
Director of research
Alzheimer's Society